Beijing Tong Ren Tang Chinese Medicine Co Ltd (HK:3613)
:3613
Want to see HK:3613 full AI Analyst Report?
Total Valuation
Beijing Tong Ren Tang Chinese Medicine Co has a market cap or net worth of HK$5.94B. The enterprise value is HK$3.88B.
Market CapHK$5.94B
Enterprise ValueHK$3.88B
Share Statistics
Beijing Tong Ren Tang Chinese Medicine Co has 837,100,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding837,100,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Beijing Tong Ren Tang Chinese Medicine Co’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.66%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)8.66%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.94M
Profits Per Employee507.95K
Employee Count782
Asset Turnover0.32
Inventory Turnover0.44
Valuation Ratios
The current PE Ratio of Beijing Tong Ren Tang Chinese Medicine Co is 17.8. Beijing Tong Ren Tang Chinese Medicine Co’s PEG ratio is -0.82.
PE Ratio17.8
PS Ratio4.68
PB Ratio1.69
Price to Fair Value1.69
Price to FCF8.56
Price to Operating Cash Flow6.74
PEG Ratio-0.82
Income Statement
In the last 12 months, Beijing Tong Ren Tang Chinese Medicine Co had revenue of 1.51B and earned 397.22M in profits. Earnings per share was 0.47.
Revenue1.51B
Gross Profit925.58M
Operating Income472.24M
Pretax Income504.69M
Net Income397.22M
EBITDA495.52M
Earnings Per Share (EPS)0.47
Cash Flow
In the last 12 months, operating cash flow was 843.38M and capital expenditures -41.18M, giving a free cash flow of 802.20M billion.
Operating Cash Flow843.38M
Free Cash Flow802.20M
Free Cash Flow per Share0.96
Dividends & Yields
Beijing Tong Ren Tang Chinese Medicine Co pays an annual dividend of HK$0.35, resulting in a dividend yield of 4.04%
Dividend Per ShareHK$0.35
Dividend Yield4.04%
Payout Ratio56.91%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change-14.35%
50-Day Moving Average7.71
200-Day Moving Average8.59
Relative Strength Index (RSI)32.27
Average Volume (3m)1.10M
Important Dates
Beijing Tong Ren Tang Chinese Medicine Co upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMar 20, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
Beijing Tong Ren Tang Chinese Medicine Co as a current ratio of 19.65, with Debt / Equity ratio of 3.02%
Current Ratio19.65
Quick Ratio13.16
Debt to Market Cap<0.01
Net Debt to EBITDA-4.24
Interest Coverage Ratio83.43
Taxes
In the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co has paid 87.83M in taxes.
Income Tax87.83M
Effective Tax Rate0.17
Enterprise Valuation
Beijing Tong Ren Tang Chinese Medicine Co EV to EBITDA ratio is 10.05, with an EV/FCF ratio of 6.02.
EV to Sales3.29
EV to EBITDA10.05
EV to Free Cash Flow6.02
EV to Operating Cash Flow5.74
Balance Sheet
Beijing Tong Ren Tang Chinese Medicine Co has HK$2.28B in cash and marketable securities with HK$126.54M in debt, giving a net cash position of HK$2.15B billion.
Cash & Marketable SecuritiesHK$2.28B
Total DebtHK$126.54M
Net CashHK$2.15B
Net Cash Per ShareHK$2.57
Tangible Book Value Per ShareHK$5.14
Margins
Gross margin is 61.16%, with operating margin of 31.20%, and net profit margin of 26.25%.
Gross Margin61.16%
Operating Margin31.20%
Pretax Margin33.35%
Net Profit Margin26.25%
EBITDA Margin32.74%
EBIT Margin31.45%
Analyst Forecast
The average price target for Beijing Tong Ren Tang Chinese Medicine Co is HK$10.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$10.50
Price Target Upside21.95% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-6.10%
EPS Growth Forecast-20.60%